Steven Peskin, MD, MBA, FACP: We have not embraced clinical pathways in the way that we’re saying that we’re working with a particular third-party clinical pathway company. What we are doing is ...

"What has been missing is the patient's perspective," says one industry consultant. The future of clinical pathways is patient-centric: an approach that balances the long-standing focus on ...

The complexity of cancer care and unwarranted variation in treatment can serve as a barrier to improving care quality. As a result, health systems are increasingly turning to clinical pathways as a ...

Dawn Holcombe's recent article in Journal of Oncology Practice/The American Journal of Managed Care joint issue, entitled Oncology Managed Programs for Payers and Physicians: Evaluating Current Models ...

Reducing drug spend is one of the greatest challenges for practices participating in the Oncology Care Model (OCM). Evidence-based clinical pathways have the potential to decrease drug spend while ...

In the realm of oncology, the advent of clinical pathways has gained substantial traction in the past two decades as the increasing cost and complexity of cancer care demanded structured, ...